Cargando…
Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC), a common digestive system cancer, is highly malignant and has a poor disease outcome. Currently, all available examination and detection methods cannot accurately predict the clinical outcome. Therefore, it is extremely important to identify novel molecular b...
Autores principales: | Jin, Kaizhou, Luo, Guopei, Xiao, Zhiwen, Liu, Zuqiang, Liu, Chen, Ji, Shunrong, Xu, Jin, Liu, Liang, Long, Jiang, Ni, Quanxing, Yu, Xianjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348055/ https://www.ncbi.nlm.nih.gov/pubmed/25750521 http://dx.doi.org/10.2147/DDDT.S77597 |
Ejemplares similares
-
Molecular Mechanism Underlying Lymphatic Metastasis in Pancreatic Cancer
por: Xiao, Zhiwen, et al.
Publicado: (2014) -
The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer
por: Guo, Meng, et al.
Publicado: (2016) -
Prognosis of distal pancreatic cancers controlled by stage
por: Luo, Guopei, et al.
Publicado: (2020) -
Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour Patients
por: Gong, Yitao, et al.
Publicado: (2020) -
Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma
por: Qian, Yunzhen, et al.
Publicado: (2020)